A Study of NB003 in Patients With Advanced Malignancies

Clinical trial NCT04936178 · COMPLETED

Trial details

NCT number: NCT04936178
Sponsor: Ningbo Newbay Technology Development Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2021-08-06
Primary completion: 2025-08-01
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.